Alumni Students Diversity Pharmacy Scholarship
According to former Skaggs School Director of Student Services Beverly Brunson, her career was a happy accident, spanning nearly three decades, changing thousands of lives, and redefining how we see the face of pharmacy.
Jordan Kellerman | 
March 22, 2021
Pharmacists are known for being medication experts who take their role of patient education seriously. 2012 PharmD alum James Delk has created a way to make that serious message, well, fresh.
Lori Westermann | February 10, 2021
NewsMedical
December 28, 2021
Krishna Mallela, PhD, and his team received press coverage for the lab’s work on SARS-CoV-2 variants, which focused on the study which highlights the importance of positive and negative selection in evolution of SARS-CoV-2 variants.
Health.com
December 28, 2021
Both Pfizer’s Paxlovid and Merck’s molnupiravir are cleared for emergency use in non-hospitalized people who have mild-to-moderate symptoms and are at heightened risk of developing severe disease. Peter Anderson, PharmD spoke with Health regarding their effectiveness.
The Guardian
December 28, 2021
Peter Anderson, PharmD spoke with the Guardian about Paxlovid and molnupiravir, which were authorized by the FDA recently. Supplies of Paxlovid are limited while molnupiravir is less effective than hoped, but they are a very important step forward.
Vanguard
December 14, 2021
Cindy O’Bryant, PharmD, had her recent Fulbright-sponsored work in Nigeria featured in a Vanguard article. The story examines the work being done to help reduce the high incidence of cancer, tackle late detection and improve general outlook of cancer in Nigeria.
